S. J. DESOLMS

3.4k total citations
39 papers, 2.2k citations indexed

About

S. J. DESOLMS is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, S. J. DESOLMS has authored 39 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 17 papers in Organic Chemistry and 8 papers in Oncology. Recurrent topics in S. J. DESOLMS's work include Protein Kinase Regulation and GTPase Signaling (11 papers), Cancer-related Molecular Pathways (5 papers) and Analytical Chemistry and Chromatography (4 papers). S. J. DESOLMS is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (11 papers), Cancer-related Molecular Pathways (5 papers) and Analytical Chemistry and Chromatography (4 papers). S. J. DESOLMS collaborates with scholars based in United States. S. J. DESOLMS's co-authors include Elizabeth A. Giuliani, Nancy E. Kohl, Samuel Graham, W. Wayt Gibbs, Allen Oliff, Joseph P. Vacca, Scott D. Mosser, Joel R. Huff, Robert L. Smith and David L. Pompliano and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

S. J. DESOLMS

39 papers receiving 2.1k citations

Peers

S. J. DESOLMS
Chuan Shih United States
Dolatrai M. Vyas United States
Gregory D. Vite United States
Patrick A. Marcotte United States
Lisa M. Shewchuk United States
Sanjeev Shangary United States
Gerd Bader Germany
Chuan Shih United States
S. J. DESOLMS
Citations per year, relative to S. J. DESOLMS S. J. DESOLMS (= 1×) peers Chuan Shih

Countries citing papers authored by S. J. DESOLMS

Since Specialization
Citations

This map shows the geographic impact of S. J. DESOLMS's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. J. DESOLMS with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. J. DESOLMS more than expected).

Fields of papers citing papers by S. J. DESOLMS

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. J. DESOLMS. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. J. DESOLMS. The network helps show where S. J. DESOLMS may publish in the future.

Co-authorship network of co-authors of S. J. DESOLMS

This figure shows the co-authorship network connecting the top 25 collaborators of S. J. DESOLMS. A scholar is included among the top collaborators of S. J. DESOLMS based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. J. DESOLMS. S. J. DESOLMS is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
MacTough, Suzanne C., S. J. DESOLMS, Anthony W. Shaw, et al.. (2001). Diaryl ether inhibitors of farnesyl-protein transferase. Bioorganic & Medicinal Chemistry Letters. 11(10). 1257–1260. 14 indexed citations
3.
Breslin, Michael J., S. J. DESOLMS, Elizabeth A. Giuliani, et al.. (1998). Potent, non-thiol inhibitors of farnesyltransferase. Bioorganic & Medicinal Chemistry Letters. 8(23). 3311–3316. 22 indexed citations
4.
DESOLMS, S. J., Elizabeth A. Giuliani, Samuel Graham, et al.. (1998). N-Arylalkyl Pseudopeptide Inhibitors of Farnesyltransferase. Journal of Medicinal Chemistry. 41(14). 2651–2656. 17 indexed citations
5.
Kral, Astrid M., Ronald E. Diehl, S. J. DESOLMS, et al.. (1997). Mutational Analysis of Conserved Residues of the -Subunit of Human Farnesyl:Protein Transferase. Journal of Biological Chemistry. 272(43). 27319–27323. 42 indexed citations
6.
Anthony, Neville J., Carolyn Buser‐Doepner, Anne L. Burkhardt, et al.. (1997). Farnesyl: proteintransferase inhibitors as agents to inhibit tumor growth. BioFactors. 6(3). 359–366. 8 indexed citations
7.
Gibbs, W. Wayt, Nancy E. Kohl, Kenneth S. Koblan, et al.. (1996). Farnesyltransferase inhibitors and anti-Ras therapy. Breast Cancer Research and Treatment. 38(1). 75–83. 34 indexed citations
8.
Koblan, Kenneth S., Scott D. Mosser, Charles A. Omer, et al.. (1995). NMR studies of novel inhibitors bound to farnesyl‐protein transferase. Protein Science. 4(4). 681–688. 30 indexed citations
9.
DESOLMS, S. J., A. A. Deana, Elizabeth A. Giuliani, et al.. (1995). Pseudodipeptide Inhibitors of Protein Farnesyltransferase. Journal of Medicinal Chemistry. 38(20). 3967–3971. 23 indexed citations
10.
Graham, Samuel, S. J. DESOLMS, Elizabeth A. Giuliani, et al.. (1994). Pseudopeptide Inhibitors of Ras Farnesyl-Protein Transferase. Journal of Medicinal Chemistry. 37(6). 725–732. 88 indexed citations
11.
Prendergast, George C., S. J. DESOLMS, Elizabeth A. Giuliani, et al.. (1994). Farnesyltransferase Inhibition Causes Morphological Reversion of ras -Transformed Cells by a Complex Mechanism That Involves Regulation of the Actin Cytoskeleton. Molecular and Cellular Biology. 14(6). 4193–4202. 177 indexed citations
12.
Kohl, Nancy E., Francine R. Wilson, Elizabeth A. Giuliani, et al.. (1994). Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice.. Proceedings of the National Academy of Sciences. 91(19). 9141–9145. 247 indexed citations
13.
Kohl, Nancy E., Scott D. Mosser, S. J. DESOLMS, et al.. (1993). Selective Inhibition of ras -Dependent Transformation by a Farnesyltransferase Inhibitor. Science. 260(5116). 1934–1937. 485 indexed citations
14.
DESOLMS, S. J., Elizabeth A. Giuliani, James P. Guare, et al.. (1991). Design and synthesis of HIV protease inhibitors. Variations of the carboxyterminus of the HIV protease inhibitor L-682,679. Journal of Medicinal Chemistry. 34(9). 2852–2857. 33 indexed citations
15.
Vacca, Joseph P., James P. Guare, S. J. DESOLMS, et al.. (1991). L-687,908, a potent hydroxyethylene containing HIV protease inhibitor. Journal of Medicinal Chemistry. 34(3). 1225–1228. 97 indexed citations
16.
Woltersdorf, Otto W., Harvey Schwam, John B. Bicking, et al.. (1989). Topically active carbonic anhydrase inhibitors. 1. O-Acyl derivatives of 6-hydroxybenzothiazole-2-sulfonamide. Journal of Medicinal Chemistry. 32(11). 2486–2492. 41 indexed citations
17.
Huff, Joel R., John J. Baldwin, S. J. DESOLMS, et al.. (1988). Structure-affinity relationships of arylquinolizines at .alpha.-adrenoceptors. Journal of Medicinal Chemistry. 31(3). 641–645. 17 indexed citations
18.
STOKKER, G. E., A. A. Deana, S. J. DESOLMS, et al.. (1982). 2-(Aminomethyl)phenols, a new class of saluretic agents. 4. Effects of oxygen and/or nitrogen substitution. Journal of Medicinal Chemistry. 25(6). 735–742. 12 indexed citations
19.
Woltersdorf, Otto W., S. J. DESOLMS, Everett M. Schultz, & Edward J. Cragoe. (1977). (Acylaryloxy)acetic acid diuretics. 1. (2-Alkyl- and 2,2-dialkyl-1-oxo-5-indanyloxy)acetic acids. Journal of Medicinal Chemistry. 20(11). 1400–1408. 18 indexed citations
20.
DESOLMS, S. J.. (1976). N,N,N′,N′-テトラメチルメタンジアミン 単純で効果的なMannich試薬 | 文献情報 | J-GLOBAL 科学技術総合リンクセンター. The Journal of Organic Chemistry. 41(15). 2650–2651. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026